Medfinder
Back to blog

Updated: January 11, 2026

What Is Forfivo XL? Uses, Dosage, and What You Need to Know in 2026

Author

Peter Daggett

Peter Daggett

Medication information educational illustration

What is Forfivo XL? It's bupropion 450 mg — a unique antidepressant for major depressive disorder. Learn its uses, dosage rules, how to take it, and who it's for in 2026.

Forfivo XL is a brand-name prescription antidepressant that contains bupropion hydrochloride — a well-known medication used to treat major depressive disorder. What makes Forfivo XL unique is its dose: it's the only commercially available single-tablet formulation containing 450 mg of bupropion extended-release, the maximum daily dose. This guide covers everything patients need to know about Forfivo XL in 2026.

What Is Forfivo XL?

Forfivo XL (bupropion hydrochloride extended-release) is an FDA-approved antidepressant manufactured by Almatica Pharma. It is classified as an aminoketone antidepressant — a unique drug class that is chemically unrelated to SSRIs, SNRIs, tricyclic antidepressants, or MAOIs. The "XL" in Forfivo XL stands for "extended-release," meaning the tablet releases bupropion slowly throughout the day from a single once-daily dose.

Bupropion itself has been FDA-approved since 1985, first under the brand name Wellbutrin. Forfivo XL is a later formulation specifically designed to deliver the maximum approved 450 mg dose in a single convenient tablet. Other bupropion products available in the U.S. include Wellbutrin XL, Wellbutrin SR, Aplenzin, and generic bupropion in various formulations.

What Is Forfivo XL Used For?

Forfivo XL is FDA-approved for a single indication: major depressive disorder (MDD) in adults. MDD is a serious mental health condition characterized by persistent sadness, loss of interest in activities, fatigue, difficulty concentrating, sleep disturbances, changes in appetite, and in severe cases, thoughts of self-harm or suicide.

Bupropion (the active ingredient in Forfivo XL) is also used off-label for several other conditions, though these specific uses are not FDA-approved for Forfivo XL:

ADHD (attention deficit hyperactivity disorder) — off-label, more commonly used in pediatric patients

SSRI-induced sexual dysfunction — as an add-on or replacement

Smoking cessation — (other bupropion products like Zyban are FDA-approved for this; Forfivo XL is NOT indicated for smoking cessation)

Forfivo XL Dosage: How Much and How Often?

Forfivo XL comes in one strength: 450 mg extended-release tablets. The dose is one tablet once daily. It can be taken with or without food. The tablet must be swallowed whole — never crushed, chewed, or divided. Breaking the extended-release coating would release too much bupropion at once, dramatically increasing seizure risk and other side effects.

Critical rule: Forfivo XL cannot be used to start bupropion treatment. Patients must first be stabilized on another bupropion formulation (such as generic bupropion XL or Wellbutrin XL) at 300 mg/day for at least 2 weeks before switching to Forfivo XL. Alternatively, patients already on 450 mg/day of another bupropion product can switch directly to Forfivo XL.

How Is Forfivo XL Different From Wellbutrin XL?

Both Forfivo XL and Wellbutrin XL contain bupropion hydrochloride as an extended-release formulation. The main difference is dose and formulation strategy:

Wellbutrin XL: Available as 150 mg and 300 mg tablets; can be used to initiate bupropion therapy; FDA-approved for MDD and seasonal affective disorder (SAD); widely stocked; has generic versions available at low cost.

Forfivo XL: Available only as 450 mg tablet; used only after titration on other bupropion; FDA-approved for MDD only (not SAD); brand-name only at the 450 mg single-tablet dose; limited pharmacy stocking.

Who Should NOT Take Forfivo XL?

Forfivo XL is contraindicated in patients who:

Have a seizure disorder or conditions that lower the seizure threshold

Have a current or past diagnosis of anorexia nervosa or bulimia

Are taking or have taken MAOIs within the last 14 days (risk of severe hypertensive crisis)

Are currently taking other bupropion products (Wellbutrin, Zyban, Aplenzin, etc.) — the combined dose would exceed safe limits

Are abruptly stopping alcohol, benzodiazepines, or barbiturates (increases seizure risk)

Are under 18 years old (not FDA-approved in pediatric patients)

Controlled Substance Status

Forfivo XL is not a controlled substance. This is an important fact for many patients: there are no DEA-mandated refill limits, no requirement for an in-person visit to get a prescription (in most states), and no special handling requirements at the pharmacy. Any licensed prescriber with standard prescribing authority can prescribe it, including telehealth providers.

How to Get Forfivo XL If Your Pharmacy Doesn't Have It

Because Forfivo XL isn't stocked at every pharmacy, patients sometimes need to shop around. medfinder helps solve this by calling pharmacies near you to identify which ones have Forfivo XL in stock. You provide your medication, dose, and ZIP code — medfinder handles the calls and texts you results. It's a paid service designed for situations exactly like this.

For cost-saving options, see: How to save money on Forfivo XL in 2026.

Frequently Asked Questions

Forfivo XL (bupropion hydrochloride 450 mg extended-release) is FDA-approved for the treatment of major depressive disorder (MDD) in adults. It is not approved for seasonal affective disorder (SAD), ADHD, or smoking cessation — although other bupropion formulations are used for some of these purposes.

Forfivo XL and Wellbutrin XL both contain bupropion hydrochloride extended-release, but they are different formulations. Wellbutrin XL is available in 150 mg and 300 mg doses and can be used to start bupropion therapy. Forfivo XL is available only as a 450 mg tablet and cannot be used to initiate treatment — it's for patients already established on 300 mg/day of another bupropion product who need dose escalation.

Like most antidepressants, Forfivo XL typically takes 2-4 weeks before patients notice meaningful improvement in mood and energy. Some patients begin to notice improvements in sleep, appetite, and anxiety within the first week. Full antidepressant effect may take 4-6 weeks or longer. Do not stop taking Forfivo XL because it doesn't seem to be working in the first few days — give it the recommended time and communicate with your prescriber about your progress.

While bupropion does not cause the same physical withdrawal syndrome seen with some other antidepressants, stopping it suddenly is still inadvisable. Abrupt discontinuation can cause a return of depressive symptoms, mood instability, and other effects. Always taper off bupropion gradually under the guidance of your prescriber. Never stop an antidepressant on your own without medical guidance.

The safety of Forfivo XL during pregnancy is not fully established. Some studies suggest potential risks to fetal heart development, while other studies have not found this association. The benefit-risk decision must be made on an individual basis with your prescriber. Bupropion does pass into breast milk, so breastfeeding mothers should discuss risks with their healthcare provider before using Forfivo XL.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards

Patients searching for Forfivo XL also looked for:

30,351 have already found their meds with Medfinder.

Start your search today.

30K+
5-star ratingTrusted by 30,351 Happy Patients
      What med are you looking for?
⊙  Find Your Meds
99% success rate
Fast turnaround time
Never call another pharmacy

Need this medication?